Why would you administer 2 mg of vitamin K?

Why Would You Give Vitamin K 2 mg?

You would give vitamin K 2 mg orally to patients on warfarin with an INR between 5 and 9 who are at increased risk of bleeding, or when more rapid INR reversal is needed for urgent surgery or dental procedures. This dose effectively reduces elevated INR within 24 hours while minimizing the risk of warfarin resistance 1.

Clinical Scenarios for 2 mg Vitamin K

Warfarin-Associated Elevated INR

The primary indication for 2 mg vitamin K is managing supratherapeutic INR in warfarin-treated patients:

• INR 5-9 with bleeding risk factors: When the INR is between 5 and 9 and the patient has risk factors predisposing to bleeding (age ≥65 years, history of stroke or GI bleeding, renal insufficiency, anemia, or concurrent antiplatelet therapy), give 1-2.5 mg vitamin K orally along with holding warfarin 1.

• Pre-procedural INR reduction: For urgent surgery or dental extraction requiring more rapid reversal, give 2-5 mg orally, anticipating INR reduction within 24 hours. An additional 1-2 mg can be given if INR remains elevated after 24 hours 1.

Important Nuances About the 2 mg Dose

The evidence shows that oral vitamin K 1.0-2.5 mg is sufficient when INR is between 4 and 10, but larger doses (5 mg) are required when INR exceeds 10 1. In a prospective study of 62 warfarin patients with INR 4-10, oral vitamin K 1 mg lowered INR below 4 in 85% and below 1.9 in 35% within 24 hours, with no warfarin resistance upon resumption 1.

However, the 2012 CHEST guidelines suggest AGAINST routine vitamin K use for INR 4.5-10 without bleeding (Grade 2B), as pooled analysis showed no difference in major bleeding, thromboembolism, or mortality compared to simply withholding warfarin 2. This creates a clinical dilemma that should be resolved by assessing individual bleeding risk.

Route of Administration Considerations

Oral administration is preferred over parenteral routes for the 2 mg dose because:

• Oral vitamin K is predictably effective and has advantages of convenience and safety over parenteral routes 1
• IV administration produces rapid response but carries risk of anaphylactic reactions 1
• Subcutaneous administration is unpredictable and sometimes delayed 1
• Oral vitamin K 1-2.5 mg more rapidly lowers INR to <5 within 24 hours than simply withholding warfarin 1

When NOT to Use 2 mg Vitamin K

Do not use 2 mg for life-threatening situations:

• Serious bleeding or major warfarin overdose (INR >20): Requires 10 mg IV vitamin K by slow infusion over 30 minutes, plus fresh frozen plasma or prothrombin complex concentrate 1
• Life-threatening bleeding: Requires prothrombin complex concentrate plus 10 mg IV vitamin K 1
• Emergency surgery requiring immediate reversal: Use 4-factor prothrombin complex concentrate (dosed by INR and weight) plus 5 mg vitamin K IV 3

Special Populations

Newborns

The 2 mg dose is NOT appropriate for neonatal prophylaxis. Newborns should receive:

• 0.5-1 mg IM within 1 hour of birth for hemorrhagic disease prophylaxis 4, 5
• 1 mg IM or SC for treatment of hemorrhagic disease of the newborn 4

INR >10 Without Bleeding

For INR >10 without bleeding, 2 mg may be insufficient. A prospective case series showed 2.5 mg oral vitamin K resulted in low major bleeding rates (3.9% by 90 days), and 2 mg was less likely to maintain INR >5 by day 3 compared to withholding warfarin alone 2. However, 3-5 mg is generally recommended for INR >9 without bleeding 1.

Common Pitfalls to Avoid

• Don't use excessive doses: High doses (10 mg) may cause warfarin resistance for up to a week 1
• Don't rely on vitamin K alone in emergencies: It takes 4-6 hours IV or 18-24 hours orally to work; use prothrombin complex concentrate for immediate reversal 6
• Don't use subcutaneous route: Response is unpredictable and delayed 1
• Don't forget to recheck INR: Monitor INR at 24 hours and repeat vitamin K if needed 1
• Document parental refusal: In neonates, if parents refuse vitamin K prophylaxis, document this due to late VKDB risk 7

Practical Algorithm

For warfarin patients with elevated INR:

1. INR 4.5-5: Hold warfarin, no vitamin K needed unless high bleeding risk
2. INR 5-9 + bleeding risk factors: Give 1-2.5 mg PO vitamin K + hold warfarin
3. INR 5-9 + urgent procedure needed: Give 2-5 mg PO vitamin K
4. INR >9 without bleeding: Give 3-5 mg PO vitamin K
5. INR >9 with bleeding or urgent surgery: Give 5-10 mg IV vitamin K + PCC

The 2 mg dose represents a balanced approach that effectively reduces INR without causing prolonged warfarin resistance, making it ideal for moderate elevations with increased bleeding risk or pre-procedural preparation.